GR
Gregory Renza
#212 out of 1697 analysts
Truist Securities
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
49.13%
Gain +1.63%
Monthly
0.02%
Yearly
0.23%
Drawdown
52.3%
$178,429.21
Equity
Holdings
$102,567.36
Cash
$75,861.84
Investment
$81,722.51
$2,802.93
Profit +$2,861
Realized
-$18,041.92
Unrealized
$20,844.86
Dividends
$570.18
$75,861.84
Cash
Deposits
$175,626.27
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.63%
Profit
$2,861
Win %
68%
This Week
Compared To Last Week
Gain
0.9%
Profit
$1,594.9
Win %
68%
This Month
Compared to last month
Gain
-3.49%
Profit
-$6,456.63
Win %
65%
This Year
Compared to last year
Gain
3.45%
Profit
$5,952.88
Win %
63%
ONC BeOne Medicines, Ltd. American Depositary Receipt
+6.25%
+$450.98 
NRIX Nurix Therapeutics Inc.
+5.45%
+$193.99 
VRDN Viridian Therapeutics Inc.
+5.44%
+$254.82 
ABVX Abivax SA ADR
+5.13%
+$1,078.04 
MNKD MannKind Corporation
+4.8%
+$90.89 
AGIO Agios Pharmaceuticals Inc.
+4.39%
+$96.33 
ZYME Zymeworks Inc.
+4%
+$377.05 
GILD Gilead Sciences Inc.
+3.18%
+$221.18 
REGN Regeneron Pharmaceuticals, Inc.
+2.69%
+$63.66 
XNCR Xencor Inc.
+2.67%
+$100.99 
NUVB Nuvation Bio Inc.
+2.24%
+$110.27 
JAZZ Jazz Pharmaceuticals plc
+2.1%
+$130.83 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 1532 | Longs Won 656/1458 44% | Profit Factor 1.01 |
| Profitability | Shorts Won 39/74 52% | Standard Deviation $1,199.3 |
| Average Win $236.52 | Best Trade (Oct 14) $6,996.26 | Sharpe Ratio -562.33 |
| Average Loss -$193.72 | Worst Trade (Mar 20) -$42,307.69 | Z-Score -11.18 (68.74%) |
| Commissions $0 | Avg. Trade Length 3m 2w 4d | Expectancy $1.83 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 36.2% | 49.16% | 58.79% | 66.74% | 73.65% | 79.82% | 85.44% | 90.62% | 95.46% |
| Consecutive Losing Trades | 921 | 829 | 737 | 645 | 552 | 460 | 368 | 276 | 184 | 92 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| ABVX Abivax SA ADR | 239.03 | $17,975.45 | $22,108.2 | - | $4,132.75 | 22.99% | +5.126% |
| AGIO Agios Pharmaceuticals Inc. | 70.83 | $1,983.31 | $2,290.02 | - | $306.71 | 15.46% | +4.391% |
 CGON CG Oncology, Inc. | 101.91 | $6,426.74 | $6,278.71 | - | -$148.03 | -2.3% | -0.372% |
| GILD Gilead Sciences Inc. | 45.32 | $6,298.55 | $7,180.23 | - | $881.68 | 14% | +3.178% |
 IDYA Ideaya Biosciences Inc. | 86.59 | $3,507.85 | $2,919.03 | - | -$588.82 | -16.79% | -0.443% |
| JAZZ Jazz Pharmaceuticals plc | 29.67 | $6,858.5 | $6,350.32 | - | -$508.18 | -7.41% | +2.104% |
| MNKD MannKind Corporation | 626.82 | $2,162.53 | $1,983.88 | - | -$178.65 | -8.26% | +4.801% |
| NRIX Nurix Therapeutics Inc. | 150.38 | $2,351.91 | $3,753.43 | - | $1,401.52 | 59.59% | +5.45% |
| NUVB Nuvation Bio Inc. | 1,050.18 | $5,194.95 | $5,025.11 | - | -$169.84 | -3.27% | +2.244% |
| ONC BeOne Medicines, Ltd. American Depositary Receipt | 20.52 | $7,468.92 | $7,662.61 | - | $193.69 | 2.59% | +6.254% |
| REGN Regeneron Pharmaceuticals, Inc. | 3.04 | $2,257.1 | $2,430.98 | - | $173.88 | 7.7% | +2.689% |
 RVMD Revolution Medicines Inc. | 83.83 | $7,327.97 | $15,950.69 | - | $8,622.72 | 117.67% | -1.674% |
| VRDN Viridian Therapeutics Inc. | 254.82 | $3,638.78 | $4,938.35 | - | $1,299.57 | 35.71% | +5.441% |
| XNCR Xencor Inc. | 161.77 | $2,534.94 | $3,884.8 | - | $1,349.86 | 53.25% | +2.669% |
| ZYME Zymeworks Inc. | 380.86 | $5,735 | $9,811 | - | $4,076 | 71.07% | +3.997% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
2026 © Marketlog. All Rights Reserved.
